Small Cap Feast
Small Cap Feast – 28 January 2019
Set Menu AIM:
Total number of AIM Companies (Incl Susp):
Total number of AIM Companies trading: *
* As at
Set Menu NEX Growth:
Total number of NEX Growth Market Companies (Incl Susp): *
Total number of NEX Growth Market Companies trading: *
* As at
Set Menu Standard List:
Total number of Standard List Companies (Incl Susp): *
Total number of Standard List Companies trading: *
* As at
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
Nasstar has left AIM following a takeover.
Nasstar has left AIM following a takeover.
Dish of the Day:
Off the Menu:
What’s Cooking in the IPO Kitchen?
Intention to float by Gemfields Group. No Capital Raise. Currently listed on JSE. (GML:JNB) at circa £122m. The Group’s key producing assets, the Kagem emerald mine in Zambia (believed to be the world’s single largest producing emerald mine) and the Montepuez ruby mine in Mozambique (one of the most significant recently discovered ruby deposits in the world), are both expected to have long mine-lives with potential for expansion. Also owns the Faberge brand. Due Valentines Day 2020.
Main Market (Standard List)
The Proof Of Trust has announced its intention to list on the Standard Market. The Blockchain based business, owns patents to a protocol which facilitates dispute resolution based upon smart contract disputes. Transaction details TBC.
Main Market (Premium)
Cabot Square—Closed ended investment fund focussed on alternative assets and asset manager. Looking to raise £200m. Will target investment opportunities that are expected to generate an attractive risk adjusted return and that can also make a positive ESG impact by focusing on some of the biggest challenges facing societies and economies. Due 14 Feb.
Calisen Group. Potential Intention to Float. Owner and manager of essential energy infrastructure assets through its subsidiaries Calvin Capital and Lowri Beck . Consolidated FY Dec 18 revenue £162.1m and operating profit £25.4m. Raising up to £300m in primary plus partial vendor sale. Expected Admission February 2020
The Global Sustainable Farmland Income Trust will invest in a diversified portfolio of operational farmland assets located in major agricultural markets including the United States, Europe, New Zealand, Australia and certain countries within Latin and South America. Raising up to $300m. Due 28 February.
Main Market (Specialist Funds)
Investment firm Nippon Active Value fund is seeking to raise up to £200m at an issue price of 100p per share via an IPO. The company aims to invest in a portfolio of quoted Japanese stocks with market capitalisations of up to $1bn. First day of dealings expected early February.
Itaconix (ITX.L) 1.425p £3.84m
The innovator in sustainable specialty polymers, announced an expansion of its high-performance detergent polymer offerings with the introduction of Itaconix® TSI™ 322 at this week’s American Cleaning Institute Convention in Orlando, Florida.
Itaconix® TSI™ 322 is the result of the Company’s ongoing engagement with current and potential customers on a new generation of non-phosphate dishwashing detergents to meet changing consumer buying behaviour. The key advance with the new polymer is the ability to deliver excellent performance while replacing multiple ingredients to achieve cost savings and more sustainable and compact products.
Sopheon (SPE.L) 795p £80.9m
Further FYDec19 trading update from the international provider of software, expertise, and best practices for Enterprise Innovation Management
The Board now expects to deliver reported revenues for the year ended 31 December 2019 of approximately $30m (2018: $34m) which is in line with market expectations. EBITDA and pre-tax profits are also expected to be in line with market expectations for the year. The year-end net cash position is expected to be $19.2m (2018: $16.7m) underlining the continued cash generative nature of the business.
The final quarter was one of the strongest on record, with revenues over $9m and with 23 license transactions signed, of which 11 were new customers.
Eagle Eye (EYE.L) 228p £58.55m
HY Dec19 update from the SaaS technology company that creates digital connections enabling personalised, real-time marketing through coupons, loyalty, apps, subscriptions and gift services . The Group has delivered another strong performance, building on the momentum from the prior year. Revenue increased 26% to £10.1m, while revenue generated by the AIR platform grew by approximately 28% to £9.6m and now represents 95% (H1 2019: 94%) of total revenue. This growth has been driven by several significant customer contracts moving to the transactional phase following successful implementations, and increased transactional revenues from existing customers, demonstrating their growing use of the AIR platform.
The growth in revenues combined with a continued focus on managing the cost base and releasing investment into the business in line with revenue growth, has resulted in a significant improvement at the EBITDA level. The Group generated adjusted EBITDA of £1.3m compared to an EBITDA loss of £(0.3)m in the comparable period of the prior year.
Concurrent Tech (CNC.L) 87.5p £63.6m
The specialist in the design and manufacture of high performance embedded computer boards for critical applications announces the launch of its first Artificial Intelligence (AI) accelerator engine..
The TR AEx/3sd-RCx has been developed to meet the specific challenges of applications such as battlefield defence, surveillance and energy exploration markets. Traditional analysis methods involve collecting data local to the application and sending that data back to a base computer for interpretation and evaluation before the results can be returned to the collection point.
This high performance board, used in conjunction with other Concurrent processor boards, employs AI techniques to enable real-time processing of external data from optical, RF and other sensors at the point of data collection. This greatly enhances vital tactical operations such as immediate object recognition, behaviour monitoring and target acquisition.
Anexo Group (ANX.L) 178.5p £196.35m
The specialist integrated credit hire and legal services provider updated on FYDec19. FY-2019 was a year of strong progress for Anexo. The Board announced that adjusted profit before tax will be in line with current market expectations. This reflects the continued expansion of the Group’s legal services division and the consequent increase in cash collection.
Anexo has continued its strategy of keeping the number of vehicles in its credit hire division (EDGE) at a consistent level. The Group has at the same time maintained its policy of increasing the number of litigators within its legal division (Bond Turner), thereby driving increased case settlements and cash collection relative to investment in new cases. The Group is pleased to announce that monthly cash collections during H2-2019 have consistently exceeded the levels achieved in H1-2019.
The Bolton office of Bond Turner continues to recruit high quality litigators and support staff and in the second half of 2019 doubled the size of its office space to almost 20,000 sq.ft. Nerw office planned for Leeds Q1 2020.
Oncimmune (ONC.L) 37.5p £23.7m
The global immunodiagnostics group, is pleased to note that a recent study led by Leeds University Academic Unit of Health Economics, supported by NIHR Leeds In Vitro Diagnostics Co-operative (NIHR Leeds MIC), and funded by The National Institute for Health Research’s (NIHR) SBRI programme, shows that using Oncimmune’s blood test in the cancer risk assessment of indeterminate pulmonary nodules (IPNs) is highly cost effective and could accelerate the time to diagnosis.
Next 15 (NFC.L) 516p £446.6m
The Group is expected to report double digit revenue and profit growth, with revenues broadly in line with expectations, after taking into account the impact of the recent strength of sterling. Organic revenue growth in H2 has followed a similar pattern from H1, excluding Beyond and Archetype organic revenue growth will be again strongly positive and NFC expects over 20% organic revenue growth in our data segment. The prospects for Beyond have improved in recent months, although the recovery to profitability has taken longer than anticipated.
Taking the above into account, adjusted profit for the year is likely to be marginally below expectations on a constant currency basis. Net debt as at 31 January 2020 is expected to be around £12m as we maintain a very prudent approach to the management of our balance sheet.
We remain confident about our prospects for the coming year and again expect double digit revenue and profit growth. We have an active acquisition pipeline and expect to complete a number of acquisitions in the next couple of months. The new business pipeline remains strong in all markets and recent material wins for the Group have included: Microsoft, REED, Photobox and Intel.
Botswana Diamonds (BOD.L) 0.675p £4.24m
Botswana Diamonds (BOD.L) 0.675p £4.24m
The Company has undertaken a placing with existing and new investors to raise £250,000 at 0.6p. Each Placing Share has one warrant attached with the right to subscribe for one new ordinary share at 0.6p per new ordinary share for a period of two years from 28th January 2020 .
The funds raised will be used to fund exploration activities during the current year in Botswana, Zimbabwe and South Africa, which remain ongoing, and to provide additional working capital for the Company.
ECSC (ECSC.L) 102.5p £9.33m
The provider of cyber security services, is delighted to announce has received an Award for Excellence at PCI London 2020, the region’s best-known gathering of payment risk and security professionals. The annual awards recognise the outstanding work across the payment card industry, reflecting demonstrable best-in-class abilities. This will be the fourth year in a row that ECSC has
Frenkel Topping (FEN.L) 48p £36.3m
The specialist independent financial advisor and asset manager focused on asset protection for vulnerable clients, notes the recent share price movement and confirms that it has received a preliminary approach from Harwood Capital LLP (“Harwood”) which could lead to an offer being made by Harwood for the entire issued and to be issued share capital of Frenkel Topping
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.